Clinical Trials Directory

Trials / Completed

CompletedNCT01930032

Pathogenic Mechanisms in C Diff Infection and Colitis

Pathogenic Mechanisms in Clostridium Difficile Infection and Colitis

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to learn more about infection by Clostridium difficile (also known as C. difficile). C. difficile is a common bacterium (a germ that may cause disease) that can live in the human gut. Some people have it without having any symptoms. In other people it can cause illness ranging from mild diarrhea to severe colitis (infection of the colon). C. difficile makes toxins that damage the cells that line the colon. The study doctors want to find out how these toxins cause damage to the cells in the colon.

Detailed description

The purpose of this study is to examine pathogenic mechanisms of Clostridium difficile toxin-mediated intestinal injury and inflammation. Two primary mechanisms will be examined. * To examine the hypothesis is that microRNA expression profiles are dysregulated by Clostridium difficile toxin exposure and that dysregulation of miRNA expression plays a role in the pathogenesis of C. difficile associated diseases. * To examine the hypothesis is that the TLR9 receptor mediates key inflammatory events in response to Clostridium difficile toxin exposure.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2013-08-28
Last updated
2017-03-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01930032. Inclusion in this directory is not an endorsement.